Varsani, H., Newton, K. R., Li, C. K., Harding, B., Holton, J., and Wedderburn, L. R. (2008).
Quantification of normal range of inflammatory changes in morphologically normal pediatric muscle.
Gunawardena H, Wedderburn LR, North J, Betteridge Z, Dunphy J, Chinoy H, Davidson JE, Cooper RG, McHugh NJ, and the Juvenile Dermatomyositis Research Group UK. (2008).
Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis.
Riley P, McCann LJ, Maillard SM, Woo P, Murray KJ, and Pilkington CA (2008).
Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis.
Marhaug, G., ShahV., Shroff, R., Varsani, H., Wedderburn, L. R., Pilkington, C. A., and Brogan, P. A. (2008).
Age dependent inhibition of ectopic calcification: A possible role for Fetuin-A and Osteopontin in patients with Juvenile Dermatomyositis with Calcinosis.
McCann, L.J., Li, C.K.C., Varsani, H., Wedderburn, L. R., and Pilkington, C.A. (2007).
Failure to over express MHC class l on muscle biopsy in a case of amyopathic juvenile dermatomyositis.
Wedderburn, L.R., McHugh, N. J., Chinoy, H., Cooper, R G., Salway, F., Ollier, W.E.R., McCann, L., Varsani, H., Dunphy, J., North, J., and Davidson, J. and on behalf of the Juvenile Dermatomyositis Research Group (JDRG). (2007).
HLA haplotype and autoantibody associations in children with juvenile dermatomyositis, and scleroderma overlap.
Wedderburn L.R, Varsani, H., Li, C.K.C., Newton, K. R., Amato, A.A., Banwell, B., Bove, K. E., Corse, A.M., Emslie-Smith, A., Harding, B., Hoogendijk, J., Lundberg, I.E., Marie S.K., Minetti C., Nennesmo I., RushingE.J., SewryC., Allen E, Charman, S.C., Pilkington,C.A., Holton, J. (the International Consensus Group on JDM Biopsy), and on behalf of the UK Juvenile Dermatomyositis Research Group (JDRG). (2007).
International consensus on a proposed score system for muscle biopsy evaluation in patients with JDM, for potential use in clinical trials.